Consequences of AphanizomenonFlos-aquae(AFA) extract (StemtechTM) on metabolic profile of patients with type 2 diabetes

Background: Blue- green algae is one of the most nutrient dense foods which is rich in substances that have useful effects on human health. The purpose of this study was to evaluate the effectiveness of a water- soluble extract of the cyanophyta Aphanizomenon Flos-aquae (StemtechTM) as a functional supplement on CD markers, lipid profile, glucose levels as well as its side effects in Iranian patients with type 2 diabetes. Methods: During this randomized, double-blind, placebo-controlled trial 49 type 2 diabetic patients, aged between 20 and 60years with a HbA1C�7.5, were allocated. Patients were divided into two groups of placebo and treated with an equal ratio 1:1. The subjects in StemtechTM group received one capsule of StemFlo (508mg) before breakfast and two capsules of StemEnhance (500mg) after each meal for a period of 12weeks, and placebo group was instructed to take placebo with the same pattern. During the intervention period, subjects were asked to keep usual diet and prohibited to take any functional foods or dietary supplements. Metabolic panel has been measured as the primary outcome of study at the beginning and end of the intervention period via blood sampling. Results: StemtechTM supplementation for 12weeks decreased fasting blood glucose (FBG) and Glycatedhemoglobin (HbA1c). Mean serum chemistry parameters (Triglyceride, Total Cholesterol, LDL, HDL, CRP, AST, ALT, BUN and Creatinine) as well as CD 34+, IL-6, TNF-aα in treated and control groups before and after the study showed no considerable dissimilarities. Conclusion: StemtechTM intervention brought in positive consequence on blood glucose levels in Iranian patients with type 2 diabetes, consequently suggests the StemtechTM as a functional food for the management of diabetes. © 2015 Sanaei et al

Energy-Efficient Service-Oriented Architecture for Mobile Cloud Handover

Mobile cloud computing uses features to deliver outsourcing data to remotely available mobile devices. However, the flexible nature of the mobile device is a critical challenge for the mobile cloud computing environment. The mobile phone significantly degrades the data transfer performance when initiating the handover process. Thus, an energy-efficient handover process could improve the quality of service (QoS). Here, we introduce a secure energy-efficient and quality-of-service architecture (EEQoSA) for the handover process in the mobile cloud computing environment. The proposed architecture involves four layers: application, the Internet protocol multimedia subsystem (IPMS), communication, and media with connectivity layers. These four layers collectively handle the energy-efficiency, security and QoS parameters. Existing service-oriented architectures designed for mobile cloud computing are based on the symmetric encryption cryptography to support different media services. However, this approach easily allows an adversary to expose the symmetric key and gain access to private data. Thus, our proposed architecture uses the secure and strong authentication (SSA) process at the IPMS layer by protecting the media services from unauthorized users, as the IPMS is the central layer that could be the entry point for an adversary. Furthermore, to extend the mobile lifetime during the handover process, an energy detection (ED) model is deployed at the communication layer to detect the energy level of the mobile device prior to the handover initialization process. The media with the connectivity layer supports the secure handover process using a priority enforcement module that allows only legitimate users to complete the re-registration process after initiating the handover. Finally, the architecture is tested using the CloudSim simulation environment and validated by a comparison with other known service-oriented architectures.https://doi.org/10.1186/s13677-017-0079-

Nurses' perceptions of aids and obstacles to the provision of optimal end of life care in ICU

Contains fulltext : 172380.pdf (publisher's version ) (Open Access

The Effect of Hydrochloric Extraction of Valerian on Number and Size of Raphe Magnus Neurons in Adult Rats

Introduction & Objective: Effective materials from Valerian officinalis L. have too much usage in the pharmacological industry. It is used as a sedative, anticonvulsion, and antidepressant drug. Serotonin has a widespread role in vital function such as sleep, awareness and calmness. In this study we evaluated the effect of hydrochloric extract of valerian on number and size of raphe magnus neurons in adult rat. Materials & Methods: In this experimental study, which was conducted at Yasuj University of Medical Sciences in 2009, forty adult Wistar rats, each 170-250 gr, were divided randomly into four groups (one control group and three experimental groups). The animals were injected daily for one month with doses of 300, 400 and 600 mg/kg of the extract. The control group just received distilled water. After transcardial perfusion, the whole brain was separated, then 10 μm sections of the brain stem were prepared, and hematoxylin and eosin (H&E) staining were done. Number and size of raphe magna neurons were observed under light microscope. The gathered data were analyzed by the SPSS software using One-way ANOVA and LSD. Results: The control group did not statistically show significant changes in number of raphe magna neurons. Comparison of the means of long and short diameter neurons showed significant increases in experimental groups with control group (P<0.05). In experimental groups the neuron nucleuses were more euchromatic than the control group. Conclusion: Hydrochloric extract of valerian has no effect on raphe magnus neurons, but it is effective on neurons' size. It can be concluded that the extract increases both neurons activity and serotonin secretion

Evaluating health promotion standards at the Farshchian heart center of Hamadan, Iran

OBJECTIVE: Farshchian Heart Center is the fifth health-promoting hospital and the first center of its type in Western Iran that officially joined the International Network of Health Promoting Hospitals and Health Services (HPH) in 2016. The purpose of the present study is to evaluate the health promotion standards at this center in 2018. METHODS: We conducted this cross-sectional study at Farshchian Heart Center of Hamadan. The main data collection instruments included questionnaires obtained from indicators of five different main standards of health-promoting hospitals developed by the World Health Organization (WHO) which were evaluated from three different perspectives: Management staff, hospital employees, and patients. The data were analyzed by SPSS version 21 software. RESULTS: We evaluated 111 hospital employees, 109 patients, and 6 management staff. Nurses (46.8) comprised the majority of the hospital staff respondents. Less than half (42.3) of the hospital staff expressed awareness of hospital health promotion policies; however, only 13.5 had attended various health promotion programs. Only 51.4 of patients knew about the hospital health promotion policies and 17.4 of them participated in relevant programs. The mean score for patient satisfaction with the hospital health promotion programs according to the visual analogue scale (VAS, range: 0-10) was 7.16 ± 2.45, which was significantly higher in outpatients (8.16 ± 1.85) compared to inpatients (6.44 ± 2.59, p = 0.001). Two thirds (66.7) of the management staff expressed awareness of implementation of these programs. CONCLUSION: The results of this study demonstrated that health promotion policies based on WHO standards were not well-recognized among patients, hospital employees, and management staff in Farshchian Heart Center of Hamadan, Iran